STAT Plus: Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?
The Readout
Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Here’s our web archive of the free email newsletter delivered daily, Monday through Friday.
Latest
STAT Plus: Exclusive: European VC Forbion hires Dyne CEO, expands in US
STAT Plus: Intellia says its CRISPR-based therapy can be redosed
STAT Plus: One firm, two conflicting takes on Alnylam’s HELIOS-B
STAT Plus: The findings from Alnylam’s highly anticipated readout
STAT Plus: Can JAK inhibitors bolster checkpoint inhibitors?
STAT Plus: Lilly takes more actions against unapproved versions of Mounjaro
STAT Plus: A biotech’s binary bet ends badly
All Coverage
